22157.jpg
Global Peptide Therapeutics Clinical Trials to 2028: Focus on Glucagon-like Peptides, Glycopeptides, Oligopeptides, Lipopeptides, Dipeptides, Opioid, Neuropeptides and Bicyclic Peptides
May 09, 2022 06:28 ET | Research and Markets
Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The global peptide...
Roots-Analysis-Logo.png
The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis
April 07, 2022 09:30 ET | Roots Analysis
London, April 07, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035” report to its list of...
22157.jpg
Peptide Therapeutics: Contract API Manufacturing Market Report 2022-2035 with Amgen, Eli Lilly, GlaxoSmithKline, Novo Nordisk and Takeda Dominating Among Others
March 24, 2022 05:38 ET | Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics: Contract API Manufacturing Market by Scale of Operation, Type of Synthesis Method Used, Company Size, and Key Geographical...
22157.jpg
Global Peptide Therapeutics Industry and Competitive Landscape Analytics 2021-2026 Featuring Profiles of Major Vendors, Including Teva Pharma, Novo Nordisk, Eli Lilly, Takeda Pharma, and GSK
October 15, 2021 04:43 ET | Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market by Application, Drug Type, Type of Manufacturing, Synthesis Technology, Solid Phase Peptide Synthesis, and Hybrid...
22157.jpg
Global Peptide Therapeutics Markets, 2021-2026 - New Drug Discovery and Product Launches in Chronic Metabolic Disorders Would Provide Fruitful Opportunities
October 05, 2021 07:08 ET | Research and Markets
Dublin, Oct. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market (2021 Edition) - Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced),...
logo.jpg
Global Peptide Drug Conjugate Market Opportunity 2026 US Europe Japan South Korea Sales Forecast 2026
April 17, 2021 05:09 ET | KuicK Research
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market and Clinical Trials Insight 2026 Report Highlights: First FDA Approved Peptide Drug Conjugate: Pepaxto...
C3 Jian Adds Two Top Oral Healthcare Professionals to Its Board of Directors
November 10, 2014 06:00 ET | C3 Jian, Inc.
LOS ANGELES, Nov. 10, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare through new pharmaceutical products, announced the appointment of Steven...
C3 Jian Closes $60M Series D Financing
March 17, 2014 15:12 ET | C3 Jian, Inc.
LOS ANGELES, March 17, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on developing proprietary drugs with an initial focus on improving oral healthcare, announced today the close...
C3 Jian Appoints Richard Bastiani to Board of Directors
October 04, 2012 17:19 ET | C3 Jian, Inc.
LOS ANGELES, Oct. 4, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced the appointment of Richard Bastiani, Ph.D., as a member of its...
C3 Jian Obtains FDA Acceptance of Investigational New Drug Application
May 24, 2012 12:06 ET | C3 Jian, Inc.
LOS ANGELES, May 24, 2012 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that its Investigational New Drug Application (IND) for...